JPH08119869A - Active oxygen suppressor - Google Patents
Active oxygen suppressorInfo
- Publication number
- JPH08119869A JPH08119869A JP6262820A JP26282094A JPH08119869A JP H08119869 A JPH08119869 A JP H08119869A JP 6262820 A JP6262820 A JP 6262820A JP 26282094 A JP26282094 A JP 26282094A JP H08119869 A JPH08119869 A JP H08119869A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- production example
- active oxygen
- leaf
- rosemary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title claims abstract description 22
- 229910052760 oxygen Inorganic materials 0.000 title claims abstract description 22
- 239000001301 oxygen Substances 0.000 title claims abstract description 22
- 239000000284 extract Substances 0.000 claims abstract description 48
- 244000178231 Rosmarinus officinalis Species 0.000 claims abstract description 13
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 12
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 12
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 12
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 12
- 235000007303 Thymus vulgaris Nutrition 0.000 claims abstract description 11
- 239000001585 thymus vulgaris Substances 0.000 claims abstract description 11
- 235000011203 Origanum Nutrition 0.000 claims abstract description 10
- 240000000783 Origanum majorana Species 0.000 claims abstract description 10
- 235000010676 Ocimum basilicum Nutrition 0.000 claims abstract description 9
- 241000196324 Embryophyta Species 0.000 claims abstract description 8
- 235000013628 Lantana involucrata Nutrition 0.000 claims abstract description 8
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 claims abstract description 8
- 240000007673 Origanum vulgare Species 0.000 claims abstract description 8
- 240000002657 Thymus vulgaris Species 0.000 claims abstract description 4
- 239000002904 solvent Substances 0.000 claims abstract description 3
- 244000062730 Melissa officinalis Species 0.000 claims abstract 3
- 240000007926 Ocimum gratissimum Species 0.000 claims abstract 3
- 239000003112 inhibitor Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 65
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 41
- 239000006210 lotion Substances 0.000 abstract description 14
- 239000006071 cream Substances 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 11
- 239000002537 cosmetic Substances 0.000 abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 9
- 239000000126 substance Substances 0.000 abstract description 5
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 229930014626 natural product Natural products 0.000 abstract description 3
- 235000013599 spices Nutrition 0.000 abstract description 3
- 239000003960 organic solvent Substances 0.000 abstract description 2
- 239000000843 powder Substances 0.000 abstract description 2
- 206010040849 Skin fissures Diseases 0.000 abstract 1
- 235000013409 condiments Nutrition 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 19
- 238000003756 stirring Methods 0.000 description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 241001529735 Melissa Species 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 8
- 241000246358 Thymus Species 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 241001529734 Ocimum Species 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- -1 Polyoxyethylene Polymers 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000001366 lippia graveolens leaf Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 235000011076 sorbitan monostearate Nutrition 0.000 description 3
- 239000001587 sorbitan monostearate Substances 0.000 description 3
- 229940035048 sorbitan monostearate Drugs 0.000 description 3
- BIIBYWQGRFWQKM-JVVROLKMSA-N (2S)-N-[4-(cyclopropylamino)-3,4-dioxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl]-2-[[(E)-3-(2,4-dichlorophenyl)prop-2-enoyl]amino]-4,4-dimethylpentanamide Chemical compound CC(C)(C)C[C@@H](C(NC(C[C@H](CCN1)C1=O)C(C(NC1CC1)=O)=O)=O)NC(/C=C/C(C=CC(Cl)=C1)=C1Cl)=O BIIBYWQGRFWQKM-JVVROLKMSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- RSIWALKZYXPAGW-NSHDSACASA-N 6-(3-fluorophenyl)-3-methyl-7-[(1s)-1-(7h-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one Chemical compound C=1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)N=C2SC=C(C)N2C(=O)C=1C1=CC=CC(F)=C1 RSIWALKZYXPAGW-NSHDSACASA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- XULSCZPZVQIMFM-IPZQJPLYSA-N odevixibat Chemical compound C12=CC(SC)=C(OCC(=O)N[C@@H](C(=O)N[C@@H](CC)C(O)=O)C=3C=CC(O)=CC=3)C=C2S(=O)(=O)NC(CCCC)(CCCC)CN1C1=CC=CC=C1 XULSCZPZVQIMFM-IPZQJPLYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- NYNZQNWKBKUAII-KBXCAEBGSA-N (3s)-n-[5-[(2r)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide Chemical compound C1[C@@H](O)CCN1C(=O)NC1=C2N=C(N3[C@H](CCC3)C=3C(=CC=C(F)C=3)F)C=CN2N=C1 NYNZQNWKBKUAII-KBXCAEBGSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- SSORSZACHCNXSJ-UHFFFAOYSA-N 2-[2-(3,4-dichlorophenyl)-3-[2-(2-hydroxypropylamino)pyrimidin-4-yl]imidazol-4-yl]acetonitrile Chemical compound ClC=1C=C(C=CC=1Cl)C=1N(C(=CN=1)CC#N)C1=NC(=NC=C1)NCC(C)O SSORSZACHCNXSJ-UHFFFAOYSA-N 0.000 description 1
- DILISPNYIVRDBP-UHFFFAOYSA-N 2-[3-[2-(2-hydroxypropylamino)pyrimidin-4-yl]-2-naphthalen-2-ylimidazol-4-yl]acetonitrile Chemical compound OC(CNC1=NC=CC(=N1)N1C(=NC=C1CC#N)C1=CC2=CC=CC=C2C=C1)C DILISPNYIVRDBP-UHFFFAOYSA-N 0.000 description 1
- DWKNOLCXIFYNFV-HSZRJFAPSA-N 2-[[(2r)-1-[1-[(4-chloro-3-methylphenyl)methyl]piperidin-4-yl]-5-oxopyrrolidine-2-carbonyl]amino]-n,n,6-trimethylpyridine-4-carboxamide Chemical compound CN(C)C(=O)C1=CC(C)=NC(NC(=O)[C@@H]2N(C(=O)CC2)C2CCN(CC=3C=C(C)C(Cl)=CC=3)CC2)=C1 DWKNOLCXIFYNFV-HSZRJFAPSA-N 0.000 description 1
- UXHQLGLGLZKHTC-CUNXSJBXSA-N 4-[(3s,3ar)-3-cyclopentyl-7-(4-hydroxypiperidine-1-carbonyl)-3,3a,4,5-tetrahydropyrazolo[3,4-f]quinolin-2-yl]-2-chlorobenzonitrile Chemical compound C1CC(O)CCN1C(=O)C1=CC=C(C=2[C@@H]([C@H](C3CCCC3)N(N=2)C=2C=C(Cl)C(C#N)=CC=2)CC2)C2=N1 UXHQLGLGLZKHTC-CUNXSJBXSA-N 0.000 description 1
- HFGHRUCCKVYFKL-UHFFFAOYSA-N 4-ethoxy-2-piperazin-1-yl-7-pyridin-4-yl-5h-pyrimido[5,4-b]indole Chemical compound C1=C2NC=3C(OCC)=NC(N4CCNCC4)=NC=3C2=CC=C1C1=CC=NC=C1 HFGHRUCCKVYFKL-UHFFFAOYSA-N 0.000 description 1
- ONPGOSVDVDPBCY-CQSZACIVSA-N 6-amino-5-[(1r)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-n-[4-(4-methylpiperazine-1-carbonyl)phenyl]pyridazine-3-carboxamide Chemical compound O([C@H](C)C=1C(=C(F)C=CC=1Cl)Cl)C(C(=NN=1)N)=CC=1C(=O)NC(C=C1)=CC=C1C(=O)N1CCN(C)CC1 ONPGOSVDVDPBCY-CQSZACIVSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- MCRWZBYTLVCCJJ-DKALBXGISA-N [(1s,3r)-3-[[(3s,4s)-3-methoxyoxan-4-yl]amino]-1-propan-2-ylcyclopentyl]-[(1s,4s)-5-[6-(trifluoromethyl)pyrimidin-4-yl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methanone Chemical compound C([C@]1(N(C[C@]2([H])C1)C(=O)[C@@]1(C[C@@H](CC1)N[C@@H]1[C@@H](COCC1)OC)C(C)C)[H])N2C1=CC(C(F)(F)F)=NC=N1 MCRWZBYTLVCCJJ-DKALBXGISA-N 0.000 description 1
- ODUIXUGXPFKQLG-QWRGUYRKSA-N [2-(4-chloro-2-fluoroanilino)-5-methyl-1,3-thiazol-4-yl]-[(2s,3s)-2,3-dimethylpiperidin-1-yl]methanone Chemical compound C[C@H]1[C@@H](C)CCCN1C(=O)C1=C(C)SC(NC=2C(=CC(Cl)=CC=2)F)=N1 ODUIXUGXPFKQLG-QWRGUYRKSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- VZUGBLTVBZJZOE-KRWDZBQOSA-N n-[3-[(4s)-2-amino-1,4-dimethyl-6-oxo-5h-pyrimidin-4-yl]phenyl]-5-chloropyrimidine-2-carboxamide Chemical compound N1=C(N)N(C)C(=O)C[C@@]1(C)C1=CC=CC(NC(=O)C=2N=CC(Cl)=CN=2)=C1 VZUGBLTVBZJZOE-KRWDZBQOSA-N 0.000 description 1
- VOVZXURTCKPRDQ-CQSZACIVSA-N n-[4-[chloro(difluoro)methoxy]phenyl]-6-[(3r)-3-hydroxypyrrolidin-1-yl]-5-(1h-pyrazol-5-yl)pyridine-3-carboxamide Chemical compound C1[C@H](O)CCN1C1=NC=C(C(=O)NC=2C=CC(OC(F)(F)Cl)=CC=2)C=C1C1=CC=NN1 VOVZXURTCKPRDQ-CQSZACIVSA-N 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 239000001331 rosmarinus officinalis leaf Substances 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- KMIOJWCYOHBUJS-HAKPAVFJSA-N vorolanib Chemical compound C1N(C(=O)N(C)C)CC[C@@H]1NC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C KMIOJWCYOHBUJS-HAKPAVFJSA-N 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Seasonings (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は活性酸素抑制剤として化
粧品、医薬品、食品に応用される植物由来の活性酸素抑
制剤に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a plant-derived active oxygen inhibitor applied as an active oxygen inhibitor to cosmetics, pharmaceuticals and foods.
【0002】[0002]
【従来の技術】ペパーミント、オレガノ、マジョラム、
タイム、メリッサ、ローズマリー、バジルの葉は香辛料
として広く食用として用いられている。BACKGROUND OF THE INVENTION Peppermint, oregano, marjoram,
Thyme, melissa, rosemary and basil leaves are widely used as spices for food.
【0003】[0003]
【発明が解決しようとする課題】本発明の目的は、天然
物で人体に安全であることが分かっており、しかも強い
活性酸素抑制作用のある物質で、できれば活性酸素抑制
作用以外の効果も発揮するような活性酸素抑制剤を提供
することにある。It is an object of the present invention that it is known that it is a natural product and safe for the human body, and it has a strong active oxygen inhibitory action, and if possible, exerts an effect other than the active oxygen inhibitory action. It is to provide such an active oxygen inhibitor.
【0004】[0004]
【課題を解決するための手段】本発明者らは、前記の課
題を解決するため、すでに多年にわたって食用に供さ
れ、人体に対する安全性が確認されている植物をスクリ
ーニングして調べ、化粧品として利用価値のあるものを
検討した。その結果、ペパーミント、オレガノ、マジョ
ラム、タイム、メリッサ、ローズマリー、バジルの葉が
非常に化粧品原料として、或いは医薬部外品としての有
効性を有することを見出した。[Means for Solving the Problems] In order to solve the above problems, the present inventors screened and investigated plants that have been used for food for many years and confirmed to be safe for the human body, and used as cosmetics. Considered something of value. As a result, they have found that peppermint, oregano, marjoram, thyme, melissa, rosemary, and basil leaves are very effective as cosmetic raw materials or quasi drugs.
【0005】すなわち、本発明は、ペパーミント、オレ
ガノ、マジョラム、タイム、メリッサ、ローズマリー、
バジルからなる群より選んだ少なくとも一種の植物の葉
の溶媒抽出物を含む活性酸素抑制剤である。That is, the present invention comprises peppermint, oregano, marjoram, thyme, melissa, rosemary,
It is an active oxygen inhibitor containing at least one plant leaf solvent extract selected from the group consisting of basil.
【0006】ペパーミント、オレガノ、マジョラム、タ
イム、メリッサ、ローズマリー、バジルの葉の利用方法
としては、水或いは親水性有機溶媒例えば、エタノー
ル、メタノール、アセトン等で抽出する。しかしなが
ら、化粧品原料の抽出であるから、水或いはエタノール
或いはこれの混合溶媒での抽出が好ましいのは当然であ
る。また、場合によっては、グリセリン、1,3ブチレ
ングリコール、プロピレングリコール等の多価アルコー
ル又は多価アルコールと水の混液も抽出に利用できる。
またさらに凍結乾燥して粉体として利用することも利用
方法によっては有効である。[0006] Peppermint, oregano, marjoram, thyme, melissa, rosemary, basil leaves can be used by extraction with water or a hydrophilic organic solvent such as ethanol, methanol or acetone. However, it is natural that extraction with water, ethanol, or a mixed solvent thereof is preferable since it is extraction of cosmetic raw materials. In some cases, a polyhydric alcohol such as glycerin, 1,3 butylene glycol, propylene glycol or the like or a mixed liquid of polyhydric alcohol and water can be used for extraction.
Further, freeze-drying and using it as powder is also effective depending on the method of use.
【0007】この物質を他の化粧品原料例えばスクワラ
ン、ホホバ油等の液状油、ミツロウ、セチルアルコール
等の固体油、各種の活性剤、グリセリン、1,3ブチレ
ングリコール等の保湿剤や各種薬剤等を添加してさまざ
まな剤形の化粧料を調製することができる。例えばロー
ション、クリーム、乳液、パック等で目的に応じて利用
形態を考えればよい。[0007] This substance is used as other cosmetic raw materials such as liquid oils such as squalane and jojoba oil, solid oils such as beeswax and cetyl alcohol, various activators, humectants such as glycerin and 1,3 butylene glycol, and various drugs. It can be added to prepare cosmetics in various dosage forms. For example, a lotion, a cream, a milky lotion, a pack, or the like may be used depending on the purpose.
【0008】空気中には酸素があり、これがないと生物
(嫌気性のものを除く)は存在しえない。しかし酸素は
紫外線や酵素等の影響を受けて活性酸素になる。活性酸
素は脂肪酸を酸化し過酸化物を生成させる。生体の生体
膜のリン脂質も酸化させ、障害を与える。その上、生成
した過酸化物と活性酸素はDNAに損傷を与え、老化を
促進するといわれている。この活性酸素は、チロシンか
らメラニンを作る機構にも影響を与え皮膚の黒化にも関
与している。この活性酸素を抑制することは皮膚にとっ
て重要な、言い換えれば化粧料に求められる重要な要素
である。There is oxygen in the air, and without it, no organisms (except anaerobic ones) can exist. However, oxygen becomes active oxygen under the influence of ultraviolet rays and enzymes. Active oxygen oxidizes fatty acids and produces peroxides. It also oxidizes and damages the phospholipids of biological membranes in the body. Furthermore, it is said that the generated peroxide and active oxygen damage DNA and accelerate aging. This active oxygen also influences the mechanism of making melanin from tyrosine and is also involved in the blackening of the skin. Suppressing this active oxygen is an important factor for the skin, in other words, an important factor required for cosmetics.
【0009】[0009]
【実施例】以下に実際の利用方法である実施例を記載す
るが、本発明はこの実施例によって何ら限定されるもの
ではない。本発明で使用したペパーミント、オレガノ、
マジョラム、タイム、メリッサ、ローズマリー、バジル
の葉の抽出物の製造例を次に示す。EXAMPLE An example of an actual usage will be described below, but the present invention is not limited to this example. Used in the present invention, peppermint, oregano,
An example of the production of leaf extract of marjoram, thyme, melissa, rosemary and basil is shown below.
【0010】(製造例1)ペパーミントの葉(乾燥品)
を10gに酢酸エチル300mlを加えて時々撹拌しつつ
5日間放置した。これを濾過後エバポレートした後凍結
乾燥した。(Production Example 1) Leaf of peppermint (dry product)
Ethyl acetate (300 ml) was added to 10 g and the mixture was allowed to stand for 5 days with occasional stirring. This was filtered, evaporated and freeze-dried.
【0011】(製造例2)ペパーミントの葉(乾燥品)
を10gにエタノール300mlを加えて時々撹拌しつつ
5日間放置した。これを濾過後エバポレートした後凍結
乾燥した。(Production Example 2) Leaf of peppermint (dry product)
300 g of ethanol was added to 10 g of the above and the mixture was allowed to stand for 5 days with occasional stirring. This was filtered, evaporated and freeze-dried.
【0012】(製造例3)ペパーミントの葉(乾燥品)
を10gに50%エタノール水溶液300mlを加えて時
々撹拌しつつ5日間放置した。濾過後エバポレートした
後凍結乾燥した。(Production Example 3) Leaf of peppermint (dried product)
300 g of a 50% aqueous ethanol solution was added to 10 g and the mixture was left for 5 days with occasional stirring. It was filtered, evaporated and freeze-dried.
【0013】(製造例4)ペパーミントの葉(乾燥品)
を10gに50%メタノール水溶液300mlを加えて時
々撹拌しつつ5日間放置した。これを濾過後エバポレー
トした後凍結乾燥した。(Production Example 4) Leaf of peppermint (dry product)
300 g of 50% methanol aqueous solution was added to 10 g of the above, and the mixture was left for 5 days with occasional stirring. This was filtered, evaporated and freeze-dried.
【0014】(製造例5)オレガノの葉(乾燥品)を1
0gにエタノール300mlを加えて時々撹拌しつつ5日
間放置した。これを濾過後エバポレートした後凍結乾燥
した。(Production Example 5) 1 oregano leaf (dry product)
300 ml of ethanol was added to 0 g, and the mixture was left for 5 days with occasional stirring. This was filtered, evaporated and freeze-dried.
【0015】(製造例6)オレガノの葉(乾燥品)を1
0gに50%エタノール水溶液300mlを加えて時々撹
拌しつつ5日間放置した。濾過後エバポレートした後凍
結乾燥した。(Production Example 6) 1 leaf of oregano leaf (dried product)
300 ml of 50% ethanol aqueous solution was added to 0 g, and the mixture was left for 5 days with occasional stirring. It was filtered, evaporated and freeze-dried.
【0016】(製造例7)オレガノの葉(乾燥品)を1
0gに50%メタノール水溶液300mlを加えて時々撹
拌しつつ5日間放置した。これを濾過後エバポレートし
た後凍結乾燥した。(Production Example 7) 1 oregano leaf (dried product)
To 0 g, 300 ml of 50% aqueous methanol solution was added, and the mixture was left for 5 days with occasional stirring. This was filtered, evaporated and freeze-dried.
【0017】(製造例8)マジョラムの葉(乾燥品)を
10gに酢酸エチル300mlを加えて時々撹拌しつつ5
日間放置した。これを濾過後エバポレートした後凍結乾
燥した。(Production Example 8) 300 g of ethyl acetate was added to 10 g of marjoram leaves (dried product), and the mixture was stirred occasionally to give 5
Left for days. This was filtered, evaporated and freeze-dried.
【0018】(製造例9)マジョラムの葉(乾燥品)を
10gに50%エタノール水溶液300mlを加えて時々
撹拌しつつ5日間放置した。濾過後エバポレートした後
凍結乾燥した。(Production Example 9) To 10 g of marjoram leaves (dried product) was added 300 ml of a 50% aqueous ethanol solution, and the mixture was left for 5 days with occasional stirring. It was filtered, evaporated and freeze-dried.
【0019】(製造例10)タイムの葉(乾燥品)を1
0gに酢酸エチル300mlを加えて時々撹拌しつつ5日
間放置した。これを濾過後エバポレートした後凍結乾燥
した。(Production Example 10) 1 leaf of thyme (dried product)
300 ml of ethyl acetate was added to 0 g, and the mixture was left for 5 days with occasional stirring. This was filtered, evaporated and freeze-dried.
【0020】(製造例11)タイムの葉(乾燥品)を1
0gにエタノール300mlを加えて時々撹拌しつつ5日
間放置した。これを濾過後エバポレートした後凍結乾燥
した。(Production Example 11) 1 thyme leaf (dried product)
300 ml of ethanol was added to 0 g, and the mixture was left for 5 days with occasional stirring. This was filtered, evaporated and freeze-dried.
【0021】(製造例12)タイムの葉(乾燥品)を1
0gに50%メタノール水溶液300mlを加えて時々撹
拌しつつ5日間放置した。これを濾過後エバポレートし
た後凍結乾燥した。(Production Example 12) 1 leaf of thyme (dried product)
To 0 g, 300 ml of 50% aqueous methanol solution was added, and the mixture was left for 5 days with occasional stirring. This was filtered, evaporated and freeze-dried.
【0022】(製造例13)メリッサの葉(乾燥品)を
10gにエタノール300mlを加えて時々撹拌しつつ5
日間放置した。これを濾過後エバポレートした後凍結乾
燥した。(Production Example 13) To 10 g of Melissa leaf (dried product) was added 300 ml of ethanol, and the mixture was stirred occasionally to give 5
Left for days. This was filtered, evaporated and freeze-dried.
【0023】(製造例14)メリッサの葉(乾燥品)を
10gに50%エタノール水溶液300mlを加えて時々
撹拌しつつ5日間放置した。濾過後エバポレートした後
凍結乾燥した。(Production Example 14) To 10 g of Melissa leaf (dry product) was added 300 ml of 50% ethanol aqueous solution, and the mixture was left for 5 days with occasional stirring. It was filtered, evaporated and freeze-dried.
【0024】(製造例15)メリッサの葉(乾燥品)を
10gに50%メタノール水溶液300mlを加えて時々
撹拌しつつ5日間放置した。これを濾過後エバポレート
した後凍結乾燥した。(Production Example 15) To 10 g of Melissa leaves (dry product) was added 300 ml of 50% methanol aqueous solution, and the mixture was left for 5 days with occasional stirring. This was filtered, evaporated and freeze-dried.
【0025】(製造例16)メリッサの葉(乾燥品)を
10gに精製水300mlを加えて3時間加熱する。これ
を放冷した後濾過後凍結乾燥した。(Production Example 16) To 10 g of Melissa leaf (dry product), 300 ml of purified water was added and heated for 3 hours. This was allowed to cool, then filtered and freeze-dried.
【0026】(製造例17)ローズマリーの葉(乾燥
品)を10gに酢酸エチル300mlを加えて時々撹拌し
つつ5日間放置した。これを濾過後エバポレートした後
凍結乾燥した。Production Example 17 To 10 g of rosemary leaves (dried product) was added 300 ml of ethyl acetate, and the mixture was left for 5 days with occasional stirring. This was filtered, evaporated and freeze-dried.
【0027】(製造例18)ローズマリーの葉(乾燥
品)を10gに50%エタノール水溶液300mlを加え
て時々撹拌しつつ5日間放置した。濾過後エバポレート
した後凍結乾燥した。Production Example 18 To 10 g of rosemary leaves (dry product) was added 300 ml of 50% ethanol aqueous solution, and the mixture was left for 5 days with occasional stirring. It was filtered, evaporated and freeze-dried.
【0028】(製造例19)ローズマリーの葉(乾燥
品)を10gに50%メタノール水溶液300mlを加え
て時々撹拌しつつ5日間放置した。これを濾過後エバポ
レートした後凍結乾燥した。(Production Example 19) To 10 g of rosemary leaves (dried product) was added 300 ml of 50% methanol aqueous solution, and the mixture was left for 5 days with occasional stirring. This was filtered, evaporated and freeze-dried.
【0029】(製造例20)ローズマリーの葉(乾燥
品)を10gに精製水300mlを加えて3時間加熱す
る。これを放冷した後濾過後凍結乾燥した。(Production Example 20) To 10 g of rosemary leaf (dry product), 300 ml of purified water was added and heated for 3 hours. This was allowed to cool, then filtered and freeze-dried.
【0030】(製造例21)バジルの葉(乾燥品)を1
0gにエタノール300mlを加えて時々撹拌しつつ5日
間放置した。これを濾過後エバポレートした後凍結乾燥
した。(Production Example 21) 1 basil leaf (dry product)
300 ml of ethanol was added to 0 g, and the mixture was left for 5 days with occasional stirring. This was filtered, evaporated and freeze-dried.
【0031】 (実施例−1)ローション オリーブ油 0.5 製造例1抽出物 0.5 ポリオキシエチレン(20E.O.)ソルビタンモノステアレート 2.0 ポリオキシエチレン(60E.O.)硬化ヒマシ油 2.0 エタノール 10.0 1.0%ヒアルロン酸ナトリウム水溶液 5.0 精製水 80.0(Example-1) Lotion Olive oil 0.5 Production Example 1 Extract 0.5 Polyoxyethylene (20 E.O.) sorbitan monostearate 2.0 Polyoxyethylene (60 E.O.) hydrogenated castor oil 2.0 Ethanol 10.0 1.0% sodium hyaluronate aqueous solution 5.0 Purified water 80.0
【0032】 (実施例−2)クリーム A スクワラン 20.0 オリーブ油 2.0 ミンク油 1.0 ホホバ油 5.0 ミツロウ 5.0 セトステアリルアルコール 2.0 グリセリンモノステアレート 1.0 ソルビタンモノステアレート 2.0 製造例2抽出物 1.0 B 精製水 47.9 ポリオキシエチレン(20E.O.)ソルビタンモノステアレート 2.0 ポリオキシエチレン(60E.O.)硬化ヒマシ油 1.0 グリセリン 5.0 1.0%ヒアルロン酸ナトリウム水溶液 5.0 パラオキシ安息香酸メチル 0.1 AとBをそれぞれ計量し、70℃まで加温し、BにAを
撹拌しつつ徐々に加えたのち、ゆっくり撹拌しつつ30
℃まで冷却した。(Example-2) Cream A Squalane 20.0 Olive oil 2.0 Mink oil 1.0 Jojoba oil 5.0 Beeswax 5.0 Cetostearyl alcohol 2.0 Glycerin monostearate 1.0 Sorbitan monostearate 2.0 Production Example 2 Extract 1.0 B Purified water 47.9 Polyoxyethylene (20 E.O.) sorbitan monostearate 2.0 Polyoxyethylene (60 E.O.) hydrogenated castor oil 1.0 Glycerin 5 0.0 1.0% aqueous solution of sodium hyaluronate 5.0 Methyl paraoxybenzoate 0.1 Weigh A and B respectively, warm to 70 ° C, slowly add A to B with stirring, and then slowly stir. While doing 30
Cooled to ° C.
【0033】実施例−3は実施例−1の製造例1の抽出
物を製造例3の抽出物に変え作成したローション。Example 3 is a lotion prepared by replacing the extract of Production Example 1 of Example 1 with the extract of Production Example 3.
【0034】実施例−4は実施例−2の製造例2の抽出
物を製造例4の抽出物に変え作成したクリーム。Example 4 is a cream prepared by changing the extract of Production Example 2 of Example-2 into the extract of Production Example 4.
【0035】実施例−5は実施例−1の製造例1の抽出
物を製造例5の抽出物に変え作成したローション。Example-5 is a lotion prepared by changing the extract of Production Example-1 of Example-1 into the extract of Production Example-5.
【0036】実施例−6は実施例−2の製造例2の抽出
物を製造例6の抽出物に変え作成したクリーム。Example 6 is a cream prepared by replacing the extract of Production Example 2 of Example-2 with the extract of Production Example 6.
【0037】実施例−7は実施例−1の製造例1の抽出
物を製造例7の抽出物に変え作成したローション。Example-7 is a lotion prepared by changing the extract of Production Example 1 of Example-1 into the extract of Production Example 7.
【0038】実施例−8は実施例−2の製造例2の抽出
物を製造例8の抽出物に変え作成したクリーム。Example-8 is a cream prepared by replacing the extract of Production Example 2 of Example-2 with the extract of Production Example 8.
【0039】実施例−9は実施例−1の製造例1の抽出
物を製造例9の抽出物に変え作成したローション。Example-9 is a lotion prepared by changing the extract of Production Example 1 of Example-1 into the extract of Production Example 9.
【0040】実施例−10は実施例−2の製造例2の抽
出物を製造例10の抽出物に変え作成したクリーム。Example-10 is a cream prepared by replacing the extract of Example-2 of Example-2 with the extract of Example-10.
【0041】実施例−11は実施例−1の製造例1の抽
出物を製造例11の抽出物に変え作成したローション。Example-11 is a lotion prepared by changing the extract of Production Example 1 of Example-1 into the extract of Production Example 11.
【0042】実施例−12は実施例−2の製造例2の抽
出物を製造例12の抽出物に変え作成したクリーム。Example-12 is a cream prepared by replacing the extract of Production Example 2 of Example-2 with the extract of Production Example 12.
【0043】実施例−13は実施例−1の製造例1の抽
出物を製造例13の抽出物に変え作成したローション。Example-13 is a lotion prepared by changing the extract of Production Example 1 of Example-1 into the extract of Production Example 13.
【0044】実施例−14は実施例−2の製造例2の抽
出物を製造例14の抽出物に変え作成したクリーム。Example-14 is a cream prepared by replacing the extract of Production Example 2 of Example-2 with the extract of Production Example 14.
【0045】実施例−15は実施例−1の製造例1の抽
出物を製造例15の抽出物に変え作成したローション。Example-15 is a lotion prepared by changing the extract of Production Example-1 of Example-1 into the extract of Production Example-15.
【0046】実施例−16は実施例−2の製造例2の抽
出物を製造例16の抽出物に変え作成したクリーム。Example-16 is a cream prepared by replacing the extract of Production Example 2 of Example-2 with the extract of Production Example 16.
【0047】実施例−17は実施例−1の製造例1の抽
出物を製造例17の抽出物に変え作成したローション。Example-17 is a lotion prepared by changing the extract of Production Example 1 of Example-1 into the extract of Production Example 17.
【0048】実施例−18は実施例−2の製造例2の抽
出物を製造例18の抽出物に変え作成したクリーム。Example-18 is a cream prepared by changing the extract of Production Example 2 of Example-2 into the extract of Production Example 18.
【0049】実施例−19は実施例−1の製造例1の抽
出物を製造例19の抽出物に変え作成したローション。Example-19 is a lotion prepared by changing the extract of Production Example 1 of Example-1 into the extract of Production Example 19.
【0050】実施例−20は実施例−2の製造例2の抽
出物を製造例20の抽出物に変え作成したクリーム。Example-20 is a cream prepared by replacing the extract of Production Example 2 of Example-2 with the extract of Production Example 20.
【0051】実施例−21は実施例−1の製造例1の抽
出物を製造例21の抽出物に変え作成したローション。Example 21 is a lotion prepared by replacing the extract of Production Example 1 of Example-1 with the extract of Production Example 21.
【0052】(活性酸素抑制試験効果)活性酸素を抑制
する効果を測定する方法は各種あるが、今回和光純薬の
SODテストワコーを用いて実験した。発色試薬を1.
0ml、試料の0.1%液を0.1mlとり37℃で恒温に
したのち、酵素液1.0mlを加えて撹拌したのち、37
℃、20分間放置後、反応停止液を2.0mlを加えて5
60nmで吸光度を測定した。この試験では試料の終濃度
は0.00476%となる。製造例1〜21の抽出物に
ついて、この試験結果を表1に示す。(Effect of Active Oxygen Suppression Test) There are various methods for measuring the effect of suppressing active oxygen, but this time an experiment was carried out using SOD Test Wako of Wako Pure Chemical. Use the coloring reagent 1.
0 ml, 0.1 ml of 0.1% solution of the sample was taken to a constant temperature at 37 ° C, 1.0 ml of enzyme solution was added and stirred, and then 37
After leaving it for 20 minutes at ℃, add 2.0 ml of the reaction stop solution and add 5
Absorbance was measured at 60 nm. In this test, the final concentration of the sample is 0.00476%. The test results of the extracts of Production Examples 1 to 21 are shown in Table 1.
【0053】[0053]
【表1】 [Table 1]
【0054】(使用テスト)女性4名づつの顔面を左右
に分け、一方を実施例、もう一方を比較例として毎日、
1回以上使用してもらって、3月後、アンケートした。
なお、比較例は実施例より製造例の各種の抽出物を水に
かえたものである。(比較例1,2)なお、44名を1
1班にわけ、下記の表2試料を使って肌荒れ防止効果、
肌のつや、肌のはりについて実験した。(Usage test) The faces of four women were divided into left and right sides, one of which was used as an example and the other was used as a comparative example every day.
A questionnaire was given three months later after having used it at least once.
In addition, in the comparative example, various extracts of the production examples from the examples are replaced with water. (Comparative Examples 1 and 2) 44 people were 1
Divide into 1 group and use the following Table 2 samples to prevent rough skin,
We conducted an experiment on skin gloss and skin elasticity.
【0055】[0055]
【表2】 [Table 2]
【0056】判定基準は以下のようで、この評点のアン
ケートの結果の4名の評点の合計をまとめたのが以下の
表3である。 実施例の方が非常によい 3 実施例の方がかなりよい 2 実施例の方がややよい 1 差がない 0 比較例の方がややよい −1 比較例の方がかなりよい −2 比較例の方が非常によい −3The criteria for judgment are as follows. Table 3 below summarizes the sum of the scores of the four persons as a result of the questionnaire of this score. Example is much better 3 Example is much better 2 Example is slightly better 1 No difference 0 Comparative example is slightly better -1 Comparative example is much better -2 Comparative example Is much better -3
【0057】[0057]
【表3】 [Table 3]
【0058】[0058]
【発明の効果】活性酸素生成阻害率試験の結果より見
て、本発明の植物体の阻害効果は明らかであり、又植物
体の抽出物であるので相互反応は考えられず、2種以上
を混合しても効果は加成的であることは明らかである。
使用テストにおいても、肌荒れ防止効果、肌のつや、は
り保持効果は明らかで特に阻害率の大きいローズマリー
(製造例17,18)で、これらの効果も大きくなって
おり(実験No.9)、活性酸素抑制効果によることを裏
づけている。天然物であり、香辛料として多年使用され
ているので人の肌に対する安全性についても保証されて
いる。The inhibitory effect of the plant of the present invention is clear from the results of the active oxygen production inhibition rate test, and since it is an extract of the plant, no mutual reaction is considered and two or more species are It is clear that the effect is additive when mixed.
Even in the use test, the effect of preventing rough skin, the shine of the skin, and the effect of retaining the elasticity of the rosemary (manufacturing examples 17 and 18) having a particularly large inhibition rate were large, and these effects were also large (Experiment No. 9) This is supported by the effect of suppressing active oxygen. Since it is a natural product and has been used as a spice for many years, it is guaranteed to be safe for human skin.
Claims (1)
タイム、メリッサ、ローズマリー及びバジルからなる群
より選んだ少なくとも一種の植物の葉の溶媒抽出物を含
む活性酸素抑制剤。1. Peppermint, oregano, marjoram,
An active oxygen inhibitor comprising a solvent extract of at least one plant leaf selected from the group consisting of thyme, melissa, rosemary and basil.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6262820A JPH08119869A (en) | 1994-10-26 | 1994-10-26 | Active oxygen suppressor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6262820A JPH08119869A (en) | 1994-10-26 | 1994-10-26 | Active oxygen suppressor |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH08119869A true JPH08119869A (en) | 1996-05-14 |
Family
ID=17381075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6262820A Pending JPH08119869A (en) | 1994-10-26 | 1994-10-26 | Active oxygen suppressor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH08119869A (en) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998013055A1 (en) * | 1996-09-27 | 1998-04-02 | Takeshi Karita | Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
JPH10175842A (en) * | 1996-12-13 | 1998-06-30 | Noevir Co Ltd | Skin preparation for external use |
JPH10194915A (en) * | 1997-01-14 | 1998-07-28 | Noevir Co Ltd | Antimicrobial and low-irritating cosmetic |
JPH1112270A (en) * | 1997-06-26 | 1999-01-19 | Asahi Breweries Ltd | New compounds with antioxidant activity |
JP2001081038A (en) * | 1999-09-14 | 2001-03-27 | Nippon Zettoc Co Ltd | Scavenger for active oxygen, and cosmetic and food containing the same scavenger |
WO2002053127A1 (en) * | 2000-12-28 | 2002-07-11 | Shiseido Company, Ltd. | Agents for inhibiting or restoring skin damage caused by drying and method of evaluating the same |
KR20020062237A (en) * | 2002-04-18 | 2002-07-25 | 김대도 | Pepperpmint Matha anensis pack |
JP2004083476A (en) * | 2002-08-27 | 2004-03-18 | Horin:Kk | Tyrosinase inhibitor, demelanizing agent, fibroblast reproductive factor and estrogenic substance, and skin cosmetic |
JP2004256472A (en) * | 2003-02-27 | 2004-09-16 | Japan Science & Technology Agency | Dihydroxybenzoate derivative, production method thereof and use thereof |
JP2006008531A (en) * | 2004-06-22 | 2006-01-12 | Nagase & Co Ltd | Accelerator for producing antioxidizing enzyme and its production process |
KR100782517B1 (en) * | 2006-03-22 | 2007-12-06 | (주)아르떼르화장품 | Cosmetic composition for antioxidant or skin irritation relief containing plant extract |
JP2008024601A (en) * | 2006-07-18 | 2008-02-07 | Naris Cosmetics Co Ltd | Inhibitor for acrolein adduct formation, skin anti-aging external preparation and anti-aging food and beverage containing the same |
JP2010047593A (en) * | 2001-02-09 | 2010-03-04 | New Chapter Inc | Composition and method for smoke detoxification |
JP2010088441A (en) * | 2001-12-11 | 2010-04-22 | Soc Des Produits Nestle Sa | Composition for promotion of bone growth and maintenance of bone health |
FR2947451A1 (en) * | 2009-07-01 | 2011-01-07 | Oreal | LYOPHILISATE COMPRISING A VEGETABLE EXTRACT |
JPWO2014126199A1 (en) * | 2013-02-18 | 2017-02-02 | アークレイ株式会社 | Oxidative proteolytic enzyme activity enhancer |
JP2021017447A (en) * | 2019-07-18 | 2021-02-15 | ロート製薬株式会社 | External composition |
-
1994
- 1994-10-26 JP JP6262820A patent/JPH08119869A/en active Pending
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6190685B1 (en) | 1996-09-27 | 2001-02-20 | Takahisa Karita | Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
WO1998013055A1 (en) * | 1996-09-27 | 1998-04-02 | Takeshi Karita | Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
JPH10175842A (en) * | 1996-12-13 | 1998-06-30 | Noevir Co Ltd | Skin preparation for external use |
JPH10194915A (en) * | 1997-01-14 | 1998-07-28 | Noevir Co Ltd | Antimicrobial and low-irritating cosmetic |
JPH1112270A (en) * | 1997-06-26 | 1999-01-19 | Asahi Breweries Ltd | New compounds with antioxidant activity |
JP2001081038A (en) * | 1999-09-14 | 2001-03-27 | Nippon Zettoc Co Ltd | Scavenger for active oxygen, and cosmetic and food containing the same scavenger |
CN1294896C (en) * | 2000-12-28 | 2007-01-17 | 株式会社资生堂 | Agents for inhibiting or restoring skin damage caused by drying and method of evaluating the same |
WO2002053127A1 (en) * | 2000-12-28 | 2002-07-11 | Shiseido Company, Ltd. | Agents for inhibiting or restoring skin damage caused by drying and method of evaluating the same |
JP2010047593A (en) * | 2001-02-09 | 2010-03-04 | New Chapter Inc | Composition and method for smoke detoxification |
JP2010088441A (en) * | 2001-12-11 | 2010-04-22 | Soc Des Produits Nestle Sa | Composition for promotion of bone growth and maintenance of bone health |
KR20020062237A (en) * | 2002-04-18 | 2002-07-25 | 김대도 | Pepperpmint Matha anensis pack |
JP2004083476A (en) * | 2002-08-27 | 2004-03-18 | Horin:Kk | Tyrosinase inhibitor, demelanizing agent, fibroblast reproductive factor and estrogenic substance, and skin cosmetic |
JP2004256472A (en) * | 2003-02-27 | 2004-09-16 | Japan Science & Technology Agency | Dihydroxybenzoate derivative, production method thereof and use thereof |
JP2006008531A (en) * | 2004-06-22 | 2006-01-12 | Nagase & Co Ltd | Accelerator for producing antioxidizing enzyme and its production process |
KR100782517B1 (en) * | 2006-03-22 | 2007-12-06 | (주)아르떼르화장품 | Cosmetic composition for antioxidant or skin irritation relief containing plant extract |
JP2008024601A (en) * | 2006-07-18 | 2008-02-07 | Naris Cosmetics Co Ltd | Inhibitor for acrolein adduct formation, skin anti-aging external preparation and anti-aging food and beverage containing the same |
FR2947451A1 (en) * | 2009-07-01 | 2011-01-07 | Oreal | LYOPHILISATE COMPRISING A VEGETABLE EXTRACT |
JPWO2014126199A1 (en) * | 2013-02-18 | 2017-02-02 | アークレイ株式会社 | Oxidative proteolytic enzyme activity enhancer |
JP2021017447A (en) * | 2019-07-18 | 2021-02-15 | ロート製薬株式会社 | External composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH08119869A (en) | Active oxygen suppressor | |
JPH0977636A (en) | Beautifying and whitening cosmetic | |
JP3502415B2 (en) | Maillard reaction inhibitor | |
JPH05246837A (en) | Cosmetic | |
JP3933511B2 (en) | Skin cosmetics and beauty food and drink | |
JPH06336422A (en) | External agent for skin | |
JPH05306214A (en) | Cosmetic | |
JP3496967B2 (en) | Antiplasmin agent | |
JPH0899860A (en) | Skin external agent | |
JP2600036B2 (en) | Cosmetics | |
JP3667376B2 (en) | Hyaluronidase inhibitor | |
JPH0892053A (en) | External preparation for skin | |
JP3547155B2 (en) | Active oxygen suppressant | |
KR20200057126A (en) | Composition for Regenerating Skin and Enhancing Hair Growth Comprising Apigenin | |
JPH09315930A (en) | Cosmetic material for skin | |
JPH10236943A (en) | Skin-whitening cosmetic | |
JPH05306213A (en) | Cosmetic | |
JPH05124952A (en) | Cosmetic | |
JPH04321615A (en) | Skin medicine for external use | |
JPH10109924A (en) | Beautifying and whitening cosmetic | |
JP3611608B2 (en) | 5α-reductase inhibitor | |
JPH08217687A (en) | Tyrosinase inhibitor | |
JP2774882B2 (en) | Whitening and anti-aging cosmetics | |
JPH0597653A (en) | Cosmetic | |
JP3464038B2 (en) | Collagen synthesis promoter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051101 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060228 |